Home Health Care News June 24, 2024
On Monday, Enhabit Inc. (NYSE: EHAB) defended its strategy of taking on more Medicare Advantage (MA) revenue over the last couple of years.
It did so in yet another response to AREX Capital Management, an activist investor that owns 4.9% of Enhabit shares. Enhabit and AREX Capital – which wants to replace Enhabit’s current board members – have gone back and forth publicly over recent months. Specifically, the two have gone back and forth after Enhabit decided to remain a public, independent company after its strategic review.
“AREX continues to criticize past actions, including in many cases those that were made prior to Enhabit’s separation,” Enhabit wrote. “To be clear, seven of the proposed eight Enhabit independent directors were not...
Today's Sponsors
Today's Sponsor